February 6, 2022 View Now: Critical Path to Women Leading in Science Date: Feb 6, 2022 | 1:30 PM Eastern Time (US and Canada) Please join C-Path for a 90-minute roundtable discussing the Critical Pat
January 11, 2022 DiMe Journal Club features Critical Path for Parkinson’s 3DT initiative Join 3DT and DiMe Society, January 11, to hear about 3DT recommendations for patient engagement. C-Path’s Critical Path for
November 16, 2021-November 18, 2021 CDRC 2021 Annual Meeting C-Path’s Cure Drug Repurposing Collaboratory will host a three-day annual meeting in a virtual format, November 16-18, 2021. Tog
November 3, 2021 WEBINAR | Biomarkers of Effect: Safety Biomarkers as Disease Biomarkers When: November 3, 2021 – 10 a.m. US ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
October 28, 2021-October 29, 2021 View Now | October 28-29 | International Neonatal Consortium 2020 Virtual Workshop This two-day virtual workshop, hosted in collaboration with EMA, will bring together hundreds of INC consortia members and collabo
October 27, 2021 View Now | RDCA-DAP Professional Webinar Series: RDCA-DAP Collaboration with Clinerion for Real World Data Solutions When: Oct. 27, 2021 | 10 a.m. ET What: In this webinar, Clinerion scientists will present an existing rare disease use case
October 19, 2021-October 20, 2021 VIEW NOW | 2021 INC Scientific Meeting C-Path’s International Neonatal Consortium held its two-day annual scientific meeting in a virtual format, October 19-20, 2
October 11, 2021 View Now | RDCA-DAP Professional Webinar Series: RDCA-DAP Data Ingestion and Curation Process When: Nov. 10, 2021 | 10 a.m. ET What: In this month’s webinar, describes RDCA-DAP’s data management practices
October 3, 2021 View Now: IBD Biomarker Regulatory Science Webinar Wednesday, March 10, 10 a.m. ET The 3TR IMI project consortium and Critical Path Institute invite you to participate in the IBD
September 14, 2021 VIEW NOW | 2021 RDCA-DAP® Workshop The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat